Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01583400 · ClinicalTrials.gov registry record · NA

Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
131
Enrollment target

NCT01583400 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 131 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01583400, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
131 participants
Enrollment target

Study Summary

Primary care physicians have emerged as the predominant mental health care providers for diagnosing and treating depression. The majority of patients with mood disorders receive treatment in the primary care setting, within which approximately 10-30% of all patients present with a depressive disorder. Comprehensive 'Collaborative Care' models of depression management significantly improve depression outcomes and health-related quality of life. Core features of these programs include use of a trained depression care manager to closely coordinate with primary care clinicians, support treatment recommendations, provide patient education, conduct patient follow-up to ensure adequate treatment, and manage as-needed access to psychiatrists for patients with more complex presentations. Evidence based Collaborative Care models do not currently weave in the use of web-based or mobile technologies. These technologies offer unique features that may make collaborative depression care more effective. The digital health coaching program for depressive symptoms enhanced during Phase I of the current project is a web-based tool featuring video, text, links and graphics which provide patients with education, self-management techniques, tailored feedback, and tools for tracking treatment progress. The RESPECT-D (Re-engineering Systems of Primary Care Treatment of Depression) intervention is a collaborative depression management model for primary care. The primary objective of this project is to compare the efficacy of an enhanced Collaborative Care model for depression (RESPECT-D-E) to the standard model (RESPECT-D) for patients with minor and major depression and dysthymic disorder. This study will be a randomized controlled trial with 150 participants who are receiving antidepressant medication treatment in the primary care setting. The primary objectives are: reduction in subject reported depressive symptoms, improvement in subject reported health related quality of life and impro

Interventions

  • OTHER RESPECT-D
  • OTHER RESPECT-D-E (Enhanced)

Trial Details

FieldValue
Enrollment Target 131 participants
Start Date 2011-09
Est. Completion 2013-10
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT01583400

The ClinicalTrials.gov registry entry for NCT01583400 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which RESPECT-D is the first listed.

NCT01583400 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01583400 about?

NCT01583400 is a clinical study titled "Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial". Primary care physicians have emerged as the predominant mental health care providers for diagnosing and treating depression. The majority of patients with mood disorders receive treatment in the primary care setting, within which approximately 10-30% of all patients present with a depressive disorde...

What is the current status of trial NCT01583400?

This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2011-09. Estimated completion is 2013-10.

What interventions are being tested in trial NCT01583400?

The interventions under investigation include: RESPECT-D (OTHER), RESPECT-D-E (Enhanced) (OTHER).

Who is sponsoring clinical trial NCT01583400?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.